Jin; Meizhong
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jin; Meizhong.The latest application filed is for "imide-based modulators of proteolysis and associated methods of use".
Company Profile
20.25.38
- Jin; Meizhong - East Northport NY
- JIN; Meizhong - Wellesley MA
- Jin; Meizhong - Dix Hills NY US
- Jin; Meizhong - Dix Hils NY
- Jin; Meizhong - Farmingdale NY
Patent Activity
| Patent | Date |
|---|---|
| Compounds and methods for the targeted degradation of androgen receptor Grant 11,352,351 - Jin , et al. June 7, 2 | 2022-06-07 |
| Imide-based Modulators Of Proteolysis And Associated Methods Of Use App 20220089570 - CREW; Andrew P. ; et al. | 2022-03-24 |
| Methods And Reagents For Analyzing Protein-protein Interfaces App 20210285955 - MULVIHILL; Mark Joseph ; et al. | 2021-09-16 |
| Hepatitis B Antiviral Agents App 20210230176 - Qiu; Yao-Ling ; et al. | 2021-07-29 |
| Hepatitis B antiviral agents Grant 10,934,306 - Qiu , et al. March 2, 2 | 2021-03-02 |
| Compounds And Methods For The Enhanced Degradation Of Targeted Proteins App 20200392131 - Crew; Andrew P. ; et al. | 2020-12-17 |
| Hepatitis B Antiviral Agents App 20200317678 - Qiu; Yao-Ling ; et al. | 2020-10-08 |
| Hepatitis B antiviral agents Grant 10,738,035 - Qiu , et al. A | 2020-08-11 |
| Compounds and methods for the enhanced degradation of targeted proteins Grant 10,730,870 - Crew , et al. | 2020-08-04 |
| Hepatitis B antiviral agents Grant 10,702,528 - Qiu , et al. | 2020-07-07 |
| Compounds That Participate In Cooperative Binding And Uses Thereof App 20200199102 - MULVIHILL; Mark Joseph ; et al. | 2020-06-25 |
| Hepatitis B Antiviral Agents App 20200199143 - Qiu; Yao-Ling ; et al. | 2020-06-25 |
| Compounds That Participate In Cooperative Binding And Uses Thereof App 20200197391 - JIN; Meizhong ; et al. | 2020-06-25 |
| Hepatitis B antiviral agents Grant 10,640,511 - Qiu , et al. | 2020-05-05 |
| Hepatitis B antiviral agents Grant 10,538,532 - Qiu , et al. Ja | 2020-01-21 |
| Hepatitis B antiviral agents Grant 10,442,788 - Qiu , et al. Oc | 2019-10-15 |
| Hepatitis B Antiviral Agents App 20190216808 - Qiu; Yao-Ling ; et al. | 2019-07-18 |
| Hepatitis B antiviral agents Grant 10,301,255 - Qiu , et al. | 2019-05-28 |
| Hepatitis B antiviral agents Grant 10,280,175 - Or , et al. | 2019-05-07 |
| Hepatitis B Antiviral Agents App 20190119288 - Qiu; Yao-Ling ; et al. | 2019-04-25 |
| Hepatitis B Antiviral Agents App 20190084994 - Qiu; Yao-Ling ; et al. | 2019-03-21 |
| Hepatitis B antiviral agents Grant 10,189,846 - Qiu , et al. Ja | 2019-01-29 |
| Hepatitis B antiviral agents Grant 10,179,131 - Qiu , et al. Ja | 2019-01-15 |
| Hepatitis B antiviral agents Grant 10,179,792 - Qiu , et al. Ja | 2019-01-15 |
| Hepatitis B Antiviral Agents App 20170355701 - Qiu; Yao-Ling ; et al. | 2017-12-14 |
| Hepatitis B Antiviral Agents App 20170253609 - Qiu; Yao-Ling ; et al. | 2017-09-07 |
| Hepatitis B Antiviral Agents App 20170217974 - Or; Yat Sun ; et al. | 2017-08-03 |
| Hepatitis B Antiviral Agents App 20170022150 - Qiu; Yao-Ling ; et al. | 2017-01-26 |
| Hepatitis B Antiviral Agents App 20170014408 - Qiu; Yao-Ling ; et al. | 2017-01-19 |
| Hepatitis B Antiviral Agents App 20160332996 - Qiu; Yao-Ling ; et al. | 2016-11-17 |
| Hepatitis B Antiviral Agents App 20160289212 - Qiu; Yao-Ling ; et al. | 2016-10-06 |
| Compounds And Methods For The Enhanced Degradation Of Targeted Proteins App 20160272639 - Crew; Andrew P. ; et al. | 2016-09-22 |
| Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20160214972 - Jin; Meizhong ; et al. | 2016-07-28 |
| Substituted pteridinones for the treatment of cancer Grant 9,351,974 - Jin , et al. May 31, 2 | 2016-05-31 |
| Imide-based Modulators Of Proteolysis And Associated Methods Of Use App 20160058872 - Crew; Andrew P. ; et al. | 2016-03-03 |
| Imide-based Modulators Of Proteolysis And Associated Methods Of Use App 20150291562 - Crew; Andrew P. ; et al. | 2015-10-15 |
| Dihydropteridinones App 20140315911 - Jin; Meizhong ; et al. | 2014-10-23 |
| Fused bicyclic mTOR inhibitors Grant 8,796,455 - Chen , et al. August 5, 2 | 2014-08-05 |
| Fused Bicyclic Kinase Inhibitors App 20140088114 - Jin; Meizhong ; et al. | 2014-03-27 |
| Fused Bicyclic Kinase Inhibitors App 20130253197 - Mulvihill; Mark J. ; et al. | 2013-09-26 |
| Substituted imidazopyr- and imidazotri-azines Grant 8,481,733 - Crew , et al. July 9, 2 | 2013-07-09 |
| FUSED BICYCLIC mTOR INHIBITORS App 20130165651 - Chen; Xin ; et al. | 2013-06-27 |
| Fused bicyclic kinase inhibitors Grant 8,445,510 - Mulvihill , et al. May 21, 2 | 2013-05-21 |
| Fused bicyclic motor inhibitors Grant 8,314,111 - Chen , et al. November 20, 2 | 2012-11-20 |
| Deuterated Tyrosine Kinase Inhibitors App 20120220595 - Epstein; David M. ; et al. | 2012-08-30 |
| Fused Bicyclic Kinase Inhibitors App 20110281888 - Mulvihill; Mark J. ; et al. | 2011-11-17 |
| Furo[3,2-C]pyridines Grant 8,022,206 - Li , et al. September 20, 2 | 2011-09-20 |
| Fused Bicyclic mTOR Inhibitors App 20110218183 - Chen; Xin ; et al. | 2011-09-08 |
| FUSED BICYCLIC mTOR INHIBITORS App 20110190496 - Chen; Xin ; et al. | 2011-08-04 |
| Fused bicyclic mTOR inhibitors Grant 7,943,767 - Chen , et al. May 17, 2 | 2011-05-17 |
| Fused bicyclic mTor inhibitors Grant 7,923,555 - Chen , et al. April 12, 2 | 2011-04-12 |
| FUSED BICYCLIC mTOR INHIBITORS App 20100099679 - Chen; Xin ; et al. | 2010-04-22 |
| Fused bicyclic mTOR inhibitors Grant 7,700,594 - Chen , et al. April 20, 2 | 2010-04-20 |
| Substituted Imidazopyr- And Imidazotri-azines App 20090286768 - Crew; Andrew P. ; et al. | 2009-11-19 |
| Furo- and Thieno [3,2-c] Pyridines App 20090197864 - Li; An-Hu ; et al. | 2009-08-06 |
| Fused Bicyclic mTor Inhibitors App 20090163468 - Chen; Xin ; et al. | 2009-06-25 |
| Pyrrolopyridine kinase inhibiting compounds App 20070129364 - Dong; Han-Qing ; et al. | 2007-06-07 |
| Fused bicyclic mTOR inhibitors App 20070112005 - Chen; Xin ; et al. | 2007-05-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 